Alpha lipoic acid modulated high glucose-induced rat mesangial cell dysfunction via mTOR/p70S6K/4E-BP1 pathway

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Lv, Chuan ^a   Wu, Can ^a   Zhou, Yue Hong ^b   Shao, Ying ^a   Wang, Guan ^a   Wang, Qiu Yue ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Division of Endocrinology Shenyang No 8 Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COLLAGEN TYPE 1; FIBRONECTIN; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE INHIBITOR; S6 KINASE; STO 609; THIOCTIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; FLOW CYTOMETRY; IN VITRO STUDY; MESANGIUM CELL; METHYL THIAZOLYL TETRAZOLIUM ASSAY; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84911369878     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/658589     Document Type: Article

References (31)

1. Packham D. K., Alves T. P., Dwyer J. P., Atkins R., De Zeeuw D., Cooper M., Shahinfar S., Lewis J. B., Lambers Heerspink H. J., Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. The American Journal of Kidney Diseases 2012 59 1 75 83 10.1053/j.ajkd.2011.09.017 2-s2.0-83655201254
2. Reutens A. T., Atkins R. C., Epidemiology of diabetic nephropathy. Contributions to Nephrology 2011 170 1 7 10.1159/000324934 2-s2.0-79959282613
3. Conserva F., Pontrelli P., Accetturo M., Gesualdo L., The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics. Journal of Nephrology 2013 26 5 811 820 10.5301/jn.5000262 2-s2.0-84884656856
4. Steffes M. W., Østerby R., Chavers B., Mauer S. M., Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989 38 9 1077 1081 10.2337/diab.38.9.1077 2-s2.0-0024422014
5. Melhem M. F., Craven P. A., Liachenko J., DeRubertis F. R., α -lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. Journal of the American Society of Nephrology 2002 13 1 108 116 2-s2.0-0036140382
6. Shen Q. W., Zhu M. J., Tong J., Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by α -lipoic acid in C2C12 myotubes. The American Journal of Physiology-Cell Physiology 2007 293 4 C1395 C1403
7. Lee W. J., Lee I. K., Kim H. S., α -lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 12 2488 2494 10.1161/01.ATV.0000190667.33224.4c 2-s2.0-33644802810
8. Park K.-G., Min A.-K., Koh E. H., Kim H. S., Kim M.-O., Park H.-S., Kim Y.-D., Yoo T.-S., Jang B. K., Hwang J. S., Kim J. B., Choi H.-S., Park J.-Y., Lee I.-K., Lee K.-U., Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology 2008 48 5 1477 1486 10.1002/hep.22496 2-s2.0-56149098763
9. Targonsky E. D., Dai F., Koshkin V., Karaman G. T., Gyulkhandanyan A. V., Zhang Y., Chan C. B., Wheeler M. B., α -Lipoic acid regulates AMP-activated protein kinase and inhibits insulin secretion from beta cells. Diabetologia 2006 49 7 1587 1598 10.1007/s00125-006-0265-9 2-s2.0-33744933422
10. Golbidi S., Badran M., Laher I., Diabetes and alpha lipoic acid. Frontiers in Pharmacology 2011 2, article 69 10.3389/fphar.2011.00069 2-s2.0-84859479386
11. Saha A. K., Xu X. J., Balon T. W., Brandon A., Kraegen E. W., Ruderman N. B., Insulin resistance due to nutrient excess: is it a consequence of AMPK downregulation? Cell Cycle 2011 10 20 3447 3451 10.4161/cc.10.20.17886 2-s2.0-80055115885
12. Diesel B., Kulhanek-Heinze S., Höltje M., Brandt B., Höltje H.-D., Vollmar A. M., Kiemer A. K., α -lipoic acid as a directly binding activator of the insulin receptor: protection from hepatocyte apoptosis. Biochemistry 2007 46 8 2146 2155 10.1021/bi602547m 2-s2.0-33847631240
13. Lee S. J., Kim S. H., Kang J. G., Kim C. S., Ihm S.-H., Choi M. G., Yoo H. J., Alpha-lipoic acid inhibits endoplasmic reticulum stress-induced cell death through PI3K/Akt signaling pathway in FRTL5 thyroid cells. Hormone and Metabolic Research 2011 43 7 445 451 10.1055/s-0031-1277182 2-s2.0-79958770123
14. Bitar M. S., Ayed A. K., Abdel-Halim S. M., Isenovic E. R., Al-Mulla F., Inflammation and apoptosis in aortic tissues of aged type II diabetes: amelioration with α -lipoic acid through phosphatidylinositol 3-kinase/Akt- dependent mechanism. Life Sciences 2010 86 23-24 844 853 10.1016/j.lfs.2010.03.019 2-s2.0-77953022783
15. Xie R., Li X., Ling Y., Alpha-lipoic acid pre- and post-treatments provide protection against in vitro ischemia-reperfusion injury in cerebral endothelial cells via Akt/mTOR signaling. Brain Research 2012 1482 81 90 10.1016/j.brainres.2012.09.009 2-s2.0-84867332897
16. Hardie D. G., Signal transduction: how cells sense energy. Nature 2011 472 7342 176 177 10.1038/472176a 2-s2.0-79954509105
17. Wiza C., Nascimento E. B. M., Ouwens D. M., Role of PRAS40 in Akt and mTOR signaling in health and disease. The American Journal of Physiology-Endocrinology and Metabolism 2012 302 12 E1453 E1460 10.1152/ajpendo.00660.2011 2-s2.0-84862524611
18. Lieberthal W., Levine J. S., Mammalian target of rapamycin and the kidney. I. The signaling pathway. American Journal of Physiology-Renal Physiology 2012 303 1 F1 F10 10.1152/ajprenal.00014.2012 2-s2.0-84863323742
19. Lieberthal W., Levine J. S., The role of the mammalian target of rapamycin (mTOR) in renal disease. Journal of the American Society of Nephrology 2009 20 12 2493 2502 10.1681/ASN.2008111186 2-s2.0-72049105867
20. Eid A. A., Ford B. M., Bhandary B., Cavaglieri R. D. C., Block K., Barnes J. L., Gorin Y., Choudhury G. G., Abboud H. E., Mammalian target of rapamycin regulates nox4-Mediated podocyte depletion in diabetic renal injury. Diabetes 2013 62 8 2935 2947 10.2337/db12-1504 2-s2.0-84891689987
21. Liu L., Hu X., Cai G. Y., Lv Y., Zhuo L., Gao J.-J., Cui S.-Y., Feng Z., Fu B., Chen X. M., High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling. Nephrology Dialysis Transplantation 2012 27 1 90 100 10.1093/ndt/gfr265 2-s2.0-84863011181
22. Xu W.-W., Guan M.-P., Zheng Z.-J., Gao F., Zeng Y.-M., Qin Y., Xue Y.-M., Exendin-4 alleviates high glucose-induced rat mesangial cell dysfunction through the ampk pathway. Cellular Physiology and Biochemistry 2014 33 2 423 432 10.1159/000358623 2-s2.0-84895573645
23. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 10.1006/meth.2001.1262 2-s2.0-0035710746
24. Wang Y., Li X., Guo Y., Chan L., Guan X., α -Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor- γ coactivator-1 α signaling in the skeletal muscle of aged mice. Metabolism: Clinical and Experimental 2010 59 7 967 976 10.1016/j.metabol.2009.10.018 2-s2.0-77952833239
25. Yi X., Xu L., Hiller S., Kim H.-S., Nickeleit V., James L. R., Maeda N., Reduced expression of lipoic acid synthase accelerates diabetic nephropathy. Journal of the American Society of Nephrology 2012 23 1 103 111 2-s2.0-84862937339 10.1681/ASN.2011010003
26. Feng B., Yan X. F., Xue J. L., Xu L., Wang H., The protective effects of α -lipoic acid on kidneys in type 2 diabetic Goto-Kakisaki rats via reducing oxidative stress. International Journal of Molecular Sciences 2013 14 4 6746 6756 2-s2.0-84875442186 10.3390/ijms14046746
27. Gao J., Wang F., Wang W., Su Z., Guo C., Cao S., Emodin suppresses hyperglycemia-induced proliferation and fibronectin expression in mesangial cells via inhibiting cFLIP. PLoS ONE 2014 9 4 e93588 10.1371/journal.pone.0093588 2-s2.0-84898636326
28. Kanwar Y. S., Sun L., Xie P., Liu F.-Y., Chen S., A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annual Review of Pathology: Mechanisms of Disease 2011 6 395 423 10.1146/annurev.pathol.4.110807.092150 2-s2.0-79751477368
29. Hallows K. R., Mount P. F., Pastor-Soler N. M., Power D. A., Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. American Journal of Physiology: Renal Physiology 2010 298 5 F1067 F1077 10.1152/ajprenal.00005.2010 2-s2.0-77951581118
30. Catherwood M. A., Powell L. A., Anderson P., McMaster D., Sharpe P. C., Trimble E. R., Glucose-induced oxidative stress in mesangial cells. Kidney International 2002 61 2 599 608 10.1046/j.1523-1755.2002.00168.x 2-s2.0-0036151673
31. Zhuo L., Fu B., Bai X., NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway. Cellular Physiology and Biochemistry 2011 27 6 681 690 10.1159/000330077 2-s2.0-79959391159